Versant & MPM Back Synthetic Lethality Newco With $68M

02:49 EDT 22 Jun 2017 | SCRIP

Repare Therapeutics Inc., a Boston and Toronto-based cancer biotech, focusing on synthetic lethality, has hit the ground running with a...


Related Stories


Original Article: Versant & MPM Back Synthetic Lethality Newco With $68M


More From BioPortfolio on "Versant & MPM Back Synthetic Lethality Newco With $68M"

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...